pyrrolidonecarboxylic acid has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lachowicz, A; Pawlikowski, M; Stepień, H; Szadowska, A; Winczyk, K; Zerek-Mełeń, G | 1 |
| LePard, KJ; Mohammed, JR; Stephens, RL | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and Hyperplasia
| Article | Year |
|---|---|
Failure of tripeptide colon mitosis inhibitor to suppress the cell proliferation of dimethylhydrazine-induced colonic cancers in rats.
Topics: Adenocarcinoma; Adenoma; Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Dimethylhydrazines; Growth Inhibitors; Hyperplasia; Intestinal Mucosa; Male; Molecular Sequence Data; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar | 1993 |
Gastric ECL-cell hyperplasia produces enhanced basal and stimulated gastric acid output but not gastric erosion formation in the rat.
Topics: Animals; Carbachol; Enterochromaffin Cells; Female; Gastric Acid; Gastric Mucosa; Histamine; Hyperplasia; Indomethacin; Pentagastrin; Pyrrolidonecarboxylic Acid; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Physiological; Thyrotropin-Releasing Hormone | 1997 |